East Hill have reduced their holdings by 100,000 or so shares.
However, the latest SEC filing reports their pre-dilution holding: post dilution my estimate is that they hold about 13 % of the company. That is, unless they picked up some more in the recent secondary offer, but I doubt it.
With the exit of Hunter Hall, East Hill was the biggest shareholder by far, and at current prices is still deep underwater. I suspect they remain the biggest single holder post-offer, but we'll see with further reports.
In that regard, NASDAQ is way behind the ASX: changes in significant holdings are reported almost immediately (7 days I think) on ASX. Nasdaq allows 30 days from the end of the quarter the change occurred!
The current influenza season is a little more lethal than usual, but otherwise standard. It does highlight to analysts and new investors that, although seasonal, each year holds a sales stream. Unfortunately we always have to wait until April/May for what are essentially annual Tamiflu and Inavir sales figures.
The share price has had some dramatic fluctuations this week, springing back to $5 at its end. Whether we are seeing the last efforts of post- offer price support, or the real market in effect, I can't tell.
No comments:
Post a Comment